Results 111 to 120 of about 47,265,557 (210)

Vaginal dryness in women infected by human T-lymphotropic virus type 1: an exploratory study. [PDF]

Sex Med, 2023
Martins ALL, de Aquino Firmino A, Boa-Sorte N, Araújo JPL, Paixão TS, Viriato ARF, Galvão-Castro B, Grassi MFR.   +7 more
europepmc   +1 more source

Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1 [PDF]

, 1997
CD4 is the primary receptor for human immunodeficiency virus (HIV). The binding site for the surface glycoprotein of HIV type 1 (HIV-1), gp120, has been mapped to the C'-C" region of domain 1 of CD4. Previously, we have shown that a mutant of rat CD4, in
Puklavec, M., Stumbles, P.A., James, W, Barclay, AN, James, W., Sattentau, QJ, Stumbles, P, Somoza, C, Somoza, C., Signoret, N., Simon, J.H.M, Simon, JH, Puklavec, M, Sattentau, Q.J., Sattentau, Quentin, Barclay, A.N., Signoret, N, James, William   +17 more
core  

Tax Gene Characterization of Human T-Lymphotropic Virus Type 1 Strains from Brazilian HIV-Coinfected Patients

, 2012
The tax gene of human T-lymphotropic virus type 1 (HTLV-1) diverges among isolates according to geographic regions and has been classified into two genotypes: taxA and taxB.
de Macedo Brigido, Luis Fernando, Magri, Mariana Cavalheiro, Morimoto, Helena Kaminami, Rodrigues, Rosangela, Caterino-de-Araujo, Adele   +4 more
core   +1 more source

Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series. [PDF]

Clin Infect Dis, 2023
Meyerowitz EA, Mukerji SS, Kyle Harrold G, Erdil RM, Chen ST, Rudmann EA, Tsibris A, Venna N, Robbins GK.   +8 more
europepmc   +1 more source

The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown.

, 2009
Human T-cell lymphotropic virus type 1 prevalence estimates are usually based on serological screening of blood donors, pregnant women, and other selected population groups.
Khumalo, NP, Hlela, C, Shepperd, Sasha, Taylor, GP, Shepperd, S   +4 more
core  

Experiences from Two Decades of HTLV-1/2 Testing in a Low-Prevalence Area in Southern Germany, 2004 to 2024

Viruses
Human T-cell lymphotropic virus type 1 (HTLV-1) is a neglected pathogen with a heterogeneous global distribution. In low-prevalence areas, diagnostic testing is challenged by limited clinical awareness and the low positive predictive value of screening ...
Klaus Korn, Philipp Steininger, Barbara Schmidt, Andrea K. Thoma-Kress, Lennart Forneck, Antje Knöll   +5 more
doaj   +1 more source

[Retracted] Effects of nutrients on matrix metalloproteinases in human T‑lymphotropic virus type 1 positive and negative malignant T‑lymphocytes. [PDF]

Int J Oncol, 2023
Harakeh S, Abou-Khouzam R, Damanhouri GA, Al-Hejin A, Kumosani T, Niedzwiecki A, Rath M, Barbour E, Diab-Assaf M, Azar R.   +9 more
europepmc   +1 more source

The Clinical Pathway of Human T-Lymphotropic Virus Type-1 (HTLV-1) from Infection to Leukemia: A Comprehensive Review

Experimed
Human T-lymphotropic virus type 1 (HTLV-1), a member of the Retroviridae family, is a pathogenic retrovirus that primarily includes two clinically relevant types: HTLV-1 and HTLV-2. HTLV-1 is etiologically linked to adult T-cell leukemia/lymphoma (ATLL),
Abolfazl Jafari Sales, Aylin Golestani, Zahra Ghahremani, Kosar Soleymanpour, Kosar Hosseini Karkaj, Parya Rouhi, Mehrdad Pashazadeh, Hossein Bannazadeh Baghi, Mohaddeseh Bahmani   +8 more
doaj   +1 more source

Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection. [PDF]

Clin Microbiol Rev, 2022
Legrand N, McGregor S, Bull R, Bajis S, Valencia BM, Ronnachit A, Einsiedel L, Gessain A, Kaldor J, Martinello M.   +9 more
europepmc   +1 more source

Immigrating and vicinity are not risk factors in the prevalence and transmission rate of human T-lymphotropic virus type 1: A Survey in an endemic region of Iran and Afghan refugees. [PDF]

PLOS Glob Public Health, 2023
Mahdifar M, Akbari-Eidgahi MR, Mosavat A, Pourreza A, Akbarin MM, Valizadeh N, Rezaee SA, Rafatpanah H.   +7 more
europepmc   +1 more source